Cargando…

A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants

There is considerable interest in therapeutic transfer of regulatory T cells (Tregs) for controlling aberrant immune responses. Initial clinical trials have shown the safety of Tregs in hematopoietic stem cell transplant recipients and subjects with juvenile diabetes. Our hypothesis is that infusion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathew, James M., H.-Voss, Jessica, LeFever, Ann, Konieczna, Iwona, Stratton, Cheryl, He, Jie, Huang, Xuemei, Gallon, Lorenzo, Skaro, Anton, Ansari, Mohammed Javeed, Leventhal, Joseph R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943280/ https://www.ncbi.nlm.nih.gov/pubmed/29743501 http://dx.doi.org/10.1038/s41598-018-25574-7

Ejemplares similares

Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance
por: Mathew, James M., et al.
Publicado: (2018)

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
por: Tawhari, Ibrahim, et al.
Publicado: (2022)

Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus
por: Gallon, Lorenzo, et al.
Publicado: (2014)

The Art of Explanation: Making your Ideas, Products, and Services Easier to Understand
por: LeFever, Lee
Publicado: (2012)

Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen—Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil
por: Traitanon, Opas, et al.
Publicado: (2019)

Your patient safety survival guide: how to protect yourself and others from medical errors
por: Watson, Gretchen LeFever, et al.
Publicado: (2017)

Orbitopterional Craniotomy Resection of Pediatric Suprasellar Craniopharyngioma
por: LeFever, Devon, et al.
Publicado: (2018)

Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses
por: Levitsky, Josh, et al.
Publicado: (2016)

Intimate Partner Violence: Using Standardized Patients to Improve Trauma-Informed Care in the era of the Covid-19 Pandemic
por: Dyer, Hedda, et al.
Publicado: (2020)

Defining the Alloreactive T Cell Repertoire Using High-Throughput Sequencing of Mixed Lymphocyte Reaction Culture
por: Emerson, Ryan O., et al.
Publicado: (2014)

Ex-vivo partial nephrectomy after living donor nephrectomy: Surgical technique for expanding kidney donor pool
por: Nyame, Yaw A., et al.
Publicado: (2017)

Organ-specific regulatory T cells of thymic origin are expanded in murine prostate tumors
por: Malchow, Sven, et al.
Publicado: (2013)

A Prospective Controlled Trial to Evaluate Safety and Efficacy of in vitro Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001)
por: Oberbauer, Rainer, et al.
Publicado: (2021)

The opioid‐impaired provider: A call for national guidance to maximize rehabilitation while protecting patient safety
por: Watson, Gretchen LeFever, et al.
Publicado: (2020)

In vivo Prevention of Transplant Arteriosclerosis by ex vivo Expanded Human Regulatory T Cells
por: Nadig, Satish N., et al.
Publicado: (2010)

Mitochondrial Transfer to Host Cells from Ex Vivo Expanded Donor Hematopoietic Stem Cells
por: Kawano, Hiroki, et al.
Publicado: (2023)

Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia
por: Sarkar, Debalina, et al.
Publicado: (2014)

Neuroprotective effects of ex vivo-expanded regulatory T cells on trimethyltin-induced neurodegeneration in mice
por: Park, Seon-Young, et al.
Publicado: (2022)

Heart Transplantation in High-Risk Recipients Employing Donor Marginal Grafts Preserved With Ex-Vivo Perfusion
por: Sponga, Sandro, et al.
Publicado: (2023)

Shooting the Messenger: The Case of ADHD
por: Watson, Gretchen LeFever, et al.
Publicado: (2013)

Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells
por: Riegel, Christin, et al.
Publicado: (2019)

Clinical Outcomes and Quality of Life in Recipients of Livers Donated after Cardiac Death
por: Parikh, Neehar D., et al.
Publicado: (2015)

Utilizing Playdoh in the Classroom to Construct a 3D Model Depicting Cellular Movements and Tissue Remodeling during Human Gastrulation, Early Organogenesis, and Embryonic Folding
por: Hesterman, Ryan, et al.
Publicado: (2021)

Prevention of Allogeneic Cardiac Graft Rejection by Transfer of Ex Vivo Expanded Antigen-Specific Regulatory T-Cells
por: Takasato, Fumika, et al.
Publicado: (2014)

Extracellular Vesicles Derived From Ex Vivo Expanded Regulatory T Cells Modulate In Vitro and In Vivo Inflammation
por: Thome, Aaron D., et al.
Publicado: (2022)

Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease
por: Faridar, Alireza, et al.
Publicado: (2022)

Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneys
por: Dharia, Atit A., et al.
Publicado: (2022)

Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023)

Tackling Chronic Kidney Transplant Rejection: Challenges and Promises
por: Lai, Xingqiang, et al.
Publicado: (2021)

Adult Living-Donor Kidney Transplantation, Donor Age, and Donor–Recipient Age
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Suppression of Glomerulonephritis in NZB/NZW Lupus Prone Mice by Adoptive Transfer of Ex Vivo Expanded Regulatory T Cells
por: Scalapino, Kenneth J., et al.
Publicado: (2009)

Increased Motility and Suppression of Ex Vivo–Expanded Regulatory T Cells Designed for Adoptive Transfer Therapy in Ulcerative Colitis
por: Müller, Tanja M., et al.
Publicado: (2023)

Donor Noradrenaline Support Is Not Associated with Decreased Survival in Heart Transplant Recipients
por: Oehler, Daniel, et al.
Publicado: (2022)

Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosus
por: Laskowski, Agnieszka I., et al.
Publicado: (2019)

Author Correction: Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosus
por: Laskowski, Agnieszka I., et al.
Publicado: (2019)

Donor‐derived duodenal adenocarcinoma of a bladder‐drained pancreas allograft
por: Isaacson, Dylan, et al.
Publicado: (2022)

Recipient Outcomes with Younger Donors Undergoing Living Donor Liver Transplantation
por: Dar, Faisal S, et al.
Publicado: (2019)

Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
por: Harden, Paul N., et al.
Publicado: (2021)

Expanded criteria donors in deceased donor kidney transplantation – An Asian perspective
por: Wang, Ziting, et al.
Publicado: (2020)

Clinical effects of blood donor characteristics in transfusion recipients: protocol of a framework to study the blood donor–recipient continuum
por: Chassé, Michaël, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_aotslol0cc6v7sbvtcacn7kmi2